Busulfan and melphalan as conditioning regimen for allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia in first complete remission

Busulfan and melphalan as conditioning regimen for allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia in first complete remission

BACKGROUND: Allogeneic hematopoietic stem cell transplantation with HLA-identical donors has been established for the treatment of acute myeloid leukemia patients for over 30 years with a cure rate of 50% to 60%. OBJECTIVES: To analyze the overall survival of patients and identify factors that influ...

Full description

Bibliographic Details
Main Authors: Nadjanara Dorna Bueno, Frederico Luiz Dulley, Rosaura Saboya, José Ulysses Amigo Filho, Fabio Luiz Coracin, Dalton de Alencar Fischer Chamone
Format: Article
Language:English
Published: Elsevier 2011-06-01
Series:Revista Brasileira de Hematologia e Hemoterapia
Subjects:
Stem cell transplantation
Leukemia, myeloid, acute
Drug toxicity
Bone marrow transplantation
Busulfan
Combined modality therapy
Cyclophosphamide
Graft vs. Host disease
Survival analysis
Prognosis
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-84842011000300008

Internet

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-84842011000300008

Similar Items